“Incremental Risk of Adverse Events With Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s320, https://doi.org/10.25251/skin.8.supp.320.